Trzeciak J, Feluś E, Nolewajka E, Szaflarski J, Dudziak Z
Arch Immunol Ther Exp (Warsz). 1976;24(1):127-36.
32P-cyclophosphamide was found to combine with gamma-globulin fractions of immune sera. Immune sera incubated with 32P-cyclophosphamide retained ability to react specifically with homologous antigen in vitro in the system: MN antigens of human erythrocytes + rabbit anti-MN antibody, and probably reacted selectively with target antigens in vivo in the system: antigens of guinea pig kidney tissue + rabbit antibodies against these antigens. Hemagglutination, passive hemagglutination and precipitation in agar gel tests were used in the experiments. Ability to combine of the immune antibody + 32P-cyclophosphamide complex with homologous antigens was evaluated by measurements of radioactivity of studied materials (erythrocyte agglutinates and organ homogenates). The results indicate feasibility of using immune antibodies as carriers of cytostatic agents.
发现32P - 环磷酰胺能与免疫血清的γ - 球蛋白组分结合。用32P - 环磷酰胺孵育的免疫血清在体外系统中保留了与同源抗原特异性反应的能力:人红细胞的MN抗原 + 兔抗MN抗体,并且可能在体内系统中与靶抗原选择性反应:豚鼠肾组织抗原 + 兔抗这些抗原的抗体。实验中使用了血凝、被动血凝和琼脂凝胶沉淀试验。通过测量研究材料(红细胞凝集物和器官匀浆)的放射性来评估免疫抗体 + 32P - 环磷酰胺复合物与同源抗原结合的能力。结果表明使用免疫抗体作为细胞抑制剂载体的可行性。